Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
GZPHF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.10 | -0.15 | -0.01 | 0.17 |
| FCF Yield | 4.69% | 0.88% | -14.75% | 11.35% |
| EV / EBITDA | 28.62 | 28.50 | 10.72 | -94.96 |
| Quality | ||||
| ROIC | 1.22% | 1.22% | 3.50% | -0.57% |
| Gross Margin | 16.09% | 15.77% | 20.51% | 12.95% |
| Cash Conversion Ratio | 2.13 | – | -2.14 | – |
| Growth | ||||
| Revenue 3-Year CAGR | -6.54% | 1.01% | 1.21% | 1.94% |
| Free Cash Flow Growth | -22.18% | 105.56% | -206.35% | 273.54% |
| Safety | ||||
| Net Debt / EBITDA | 5.93 | 1.49 | -1.27 | 19.81 |
| Interest Coverage | 9.99 | 7.81 | 21.92 | -4.02 |
| Efficiency | ||||
| Inventory Turnover | 1.50 | 1.44 | 1.65 | 1.08 |
| Cash Conversion Cycle | 104.03 | 78.23 | 67.94 | 92.75 |